Logo

Quanterix

In Brief This Week: Thermo Fisher Scientific, Bruker, Quantum-Si, BioMérieux, More

News items for the week of May 16, 2022.

Quanterix Q1 Revenues up 9 Percent

The company posted Q1 2022 revenues of $29.6 million, up from $27.2 million in Q1 2021 and above the consensus Wall Street estimate of $29.1 million.

People in the News: New Appointments at Seegene, Quanterix, Deepcell, More

Stocks of Omics Tools, MDx Firms Find More Stable Footing in February After Tough Start to Year

The GenomeWeb Top 40 was flat during February while the Dow Jones, Nasdaq, and Nasdaq Biotechnology Index posted modest declines.

Quanterix Q4 Revenues Rise 16 Percent

The company posted Q4 revenues of $30.3 million, up from $26.1 million in Q4 2020, and beat the consensus Wall Street estimate of $28.5 million.

Jan 28, 2022

Emerging Single-Molecule Proteomic Technologies May Grow Into Competitors for Quanterix
Premium

Jan 13, 2022

Quanterix Projects Q4 2021 Revenues of $29M to $31M

Nov 4, 2021

Quanterix Q3 Revenues Decline 12 Percent, Beat Wall Street Estimates

Aug 5, 2021

Quanterix Revenues Almost Double in Q2

Jun 15, 2021

Study Explores Usefulness of NfL as Biomarker Across Range of Neurological Conditions
Premium

May 21, 2021

People in the News: New Appointments at Illumina, Pacific Biosciences, Qiagen, Quanterix, More

May 5, 2021

Quanterix Q1 Revenues up 73 Percent

Apr 1, 2021

GenomeWeb Index Falls Again in March, Led by 29 Percent Decline in Adaptive Biotech Stock

Mar 10, 2021

Investor Interest in Proteomics Rising on New, Improving Technologies
Premium

Mar 2, 2021

Quanterix Q4 Revenues Up 64 Percent

Mar 2, 2021

Quidel Stock Plunges in February as GenomeWeb Index Falls 3 Percent

Feb 12, 2021

Quanterix, WuXi AppTec to Open Joint Lab in Shanghai

Feb 4, 2021

Quanterix Prices $250M Public Stock Offering

Jan 14, 2021

JP Morgan Healthcare Conference 2021, Day 3: Exact Sciences, Danaher, NanoString, Bio-Techne, More

Jan 13, 2021

Quanterix Provides Preliminary Results Projecting Q4 Revenues of $24M to $26M

Nov 20, 2020

People in the News: New Appointments at Natera, Quanterix, Sophia Genetics, More

Nov 6, 2020

Quanterix Q3 Revenues Increase 111 Percent on License, Grant Revenue

Oct 6, 2020

RAD-X Awards Six Phase 2 Contracts for COVID-19 Testing

Aug 14, 2020

In Brief This Week: BGI, Illumina, Pacific Biosciences, Oxford Nanopore, Co-Diagnostics, More

Aug 7, 2020

Quanterix Prices $85M Public Stock Offering

Breaking News
The Scan

UK Moves to Allow Sale of Gene-Edited Food

The UK is moving ahead to allow the sale of gene-edited food in England, Scotland, and Wales, according to New Scientist.

Questions for the Field

Stat News writes that the alleged Buffalo shooter's citation of genetics research raises questions about what the field can do.

Cell Studies on Tumor Evolution in Mouse Model of Lung Cancer, Stereo-seq, Bacteriophage Responses

In Cell this week: tumor evolution tracked in mouse model of lung cancer, organogenesis mapped using Stereo-seq, and more.

Taking Stock of the Stockpile

The US and European countries are evaluating their smallpox vaccine stockpiles as the number of monkeypox cases increases, the Washington Post reports.